Rebecca Morse's Colleagues at Trevi Therapeutics
Rebecca Morse's Contact Details
HQ
203-304-2499
203-304-2499
Location
Meriden, Connecticut, United States
Meriden, Connecticut, United States
Company
Trevi Therapeutics
Trevi Therapeutics
Rebecca Morse's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Rebecca Morse
Rebecca Morse currently works for Trevi Therapeutics.
Rebecca Morse's role at Trevi Therapeutics is Clinical Research Associate.
Rebecca Morse's email address is ***@trevitherapeutics.com. To view Rebecca Morse's full email address, please signup to ConnectPlex.
Rebecca Morse works in the BioTech/Drugs industry.
Rebecca Morse's colleagues at Trevi Therapeutics are Jim Cassella, Anne VanLent, Farrell Simon, Jonathan Carlson, Pam Nieves, Paula Buckley, Christopher CPA and others.
Rebecca Morse's phone number is 203-304-2499